Regal Healthcare Capital Management, LLC

Regal Healthcare Capital Management, LLC is a New York-based private equity management firm established in 2017. The firm specializes in providing investment advisory services to pooled investment vehicles exempt from registration under the Investment Company Act of 1940, focusing on equity investments in private healthcare companies. The firm's owners are David Kim, MD, Jon Santemma, and Terry Wang. Regal tailors its services to each client's needs based on specific characteristics outlined in governing documents. The firm manages approximately $812 million in regulatory assets under management as of December 31, 2024, all on a discretionary basis. Regal charges an asset-based fee of 2% of committed capital for the first five years and 2% of invested capital thereafter. Additionally, the firm earns a performance-based fee based on profits, with a Carried Interest of 20% subject to an 8% hurdle rate. The firm may charge additional fees or expenses for services rendered, which may be offset against the asset-based fee. Regal's investment strategy focuses on sourcing and investing in healthcare companies with EBITDA between $2 and $10 million, emphasizing executive-first sourcing and partnerships, management buyouts, and growth capital. The firm's investments are high-risk and concentrated in the healthcare industry, with potential risks including liquidity, regulatory changes, and business risks. Regal complies with the Custody Rule and has discretionary authority to manage client accounts. The firm votes client securities on behalf of its funds and maintains a Code of Ethics to ensure fair dealings. Regal does not receive compensation for client referrals and has no disciplinary information or financial commitments impairing its ability to meet obligations.